To investigate the relationships among antibody-dependent enhancement (ADE), antibody-dependent cellular cytotoxicity (ADCC), and antibody-dependent cellular phagocytosis (ADCP) in relation to COVID-19 severity, specifically focusing on how these mechanisms may influence disease outcomes.
Key Findings:
ADE activity was significantly higher in severe COVID-19 cases compared to mild cases, indicating a potential link to disease severity.
FcγRIIa-mediated reporter activity was higher in severe cases but lost significance after adjustment for confounding factors, suggesting the need for careful interpretation.
FcγRIIIa-mediated reporter activity did not differ by severity and was notably reduced against Omicron variants, highlighting the impact of viral evolution.
Plasma from severe cases enhanced FcγR-dependent viral entry but did not lead to increased viral RNA replication in live Omicron virus infections, indicating a complex interaction.
Interpretation:
ADE activity is linked to dysregulated Fc-mediated immune responses in severe COVID-19, suggesting a potential role in excessive myeloid activation and the need for further exploration of these mechanisms.
Limitations:
The study's sample size may limit the generalizability of findings, particularly in diverse populations.
Functional assays may not fully capture the complexity of immune responses in vivo, which could affect the interpretation of results.
Conclusion:
The independent association of ADE with disease severity highlights the need for further investigation into therapeutic strategies targeting Fc–FcγR interactions, which could provide insights into managing severe COVID-19 cases.
